Behavioral
Minuteclinic Diagnostic of Ohio LLC
Minuteclinic Diagnostic of Ohio LLC was paid $15.81M by Medicaid between Jan 2018 and Dec 2024, across 79 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 20% of everything it billed.
33Billing provider infoMINUTECLINIC DIAGNOSTIC OF OHIO LLC
HILLIARD, OH 43026
HILLIARD, OH 43026
33aNPI1699747303assigned 02/06/2006
33bProvider typeProfessional Counselor
28Total paid$15.81M
24GClaims938,643
24DCodes billed79
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Professional Counselor providers in Ohio
Rank by total paid#4 of 298
Median peer was paid$27K
This provider vs. median592×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official PINCINCE, DEBORAH controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 48,551 | $1.86M | |
| 2019 | 45,618 | $1.86M | |
| 2020 | 85,068 | $1.75M | |
| 2021 | 297,609 | $5.94M | |
| 2022 | 236,996 | $3.39M | |
| 2023 | 116,057 | $506K | |
| 2024incomplete | 108,744 | $504K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 20% | 96,442 | 87,571 | $3.12M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 44,897 | 42,145 | $2.73M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 51,341 | 47,616 | $2.04M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 11% | 33,129 | 32,701 | $1.73M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 10% | 123,328 | 114,835 | $1.65M |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 8.2% | 60,971 | 55,939 | $1.30M |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 4.6% | 20,818 | 20,416 | $732K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.9% | 12,700 | 11,814 | $307K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1.6% | 15,885 | 15,465 | $260K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.3% | 18,232 | 17,724 | $210K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.2% | 9,951 | 9,244 | $192K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.1% | 2,280 | 2,256 | $180K |
67 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 13,082 | $151K |
| 90674 | <1% | 4,900 | $107K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,675 | $95K |
| 90746 | <1% | 1,346 | $86K | |
| 90715 | <1% | 2,588 | $81K | |
| 90707 | <1% | 1,071 | $78K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 1,238 | $77K |
| 90686 | <1% | 4,302 | $75K | |
| 99401 | <1% | 3,057 | $73K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,571 | $65K |
| 0001A | <1% | 424 | $37K | |
| 86580 | <1% | 6,520 | $35K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,398 | $31K |
| 90716 | <1% | 238 | $31K | |
| 90682 | <1% | 665 | $31K | |
| 0002A | <1% | 293 | $26K | |
| 0004A | <1% | 319 | $24K | |
| 99201 | <1% | 1,067 | $22K | |
| 0031A | <1% | 213 | $19K | |
| 90734 | <1% | 271 | $19K | |
| 0071A | <1% | 225 | $19K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,054 | $18K |
| 81002 | <1% | 7,048 | $16K | |
| 99402 | <1% | 453 | $16K | |
| 90750 | <1% | 110 | $15K | |
| 0011A | <1% | 163 | $15K | |
| 0072A | <1% | 146 | $12K | |
| 0064A | <1% | 140 | $11K | |
| 0081A | <1% | 121 | $11K | |
| 81025 | <1% | 1,589 | $10K | |
| 90739 | <1% | 72 | $9K | |
| 0082A | <1% | 95 | $8K | |
| 90619 | <1% | 58 | $7K | |
| 0012A | <1% | 76 | $7K | |
| 99407 | <1% | 227 | $4K | |
| 0124A | <1% | 95 | $4K | |
| 0083A | <1% | 42 | $3K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,193 | $3K |
| 0134A | <1% | 65 | $2K | |
| 90480 | <1% | 37 | $1K | |
| 82947 | <1% | 252 | $820.97 | |
| 90632 | <1% | 12 | $715.80 | |
| 86308 | <1% | 113 | $480.31 | |
| 90656 | <1% | 13 | $268.20 | |
| 87905 | <1% | 25 | $193.37 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 13 | $102.16 |
| 86328 | <1% | 27 | $38.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 42 | $29.01 |
| 90662 | <1% | 15 | $9.84 | |
| 91300 | <1% | 153 | $0.02 | |
| 91301 | <1% | 15 | $0.01 | |
| 3074F | 0% | 68,235 | $0.00 | |
| 3008F | 0% | 51,169 | $0.00 | |
| 1036F | 0% | 78,282 | $0.00 | |
| 3079F | 0% | 15,200 | $0.00 | |
| 3080F | 0% | 1,653 | $0.00 | |
| 3075F | 0% | 5,589 | $0.00 | |
| 91307 | 0% | 45 | $0.00 | |
| 1160F | 0% | 57,591 | $0.00 | |
| 3078F | 0% | 50,290 | $0.00 | |
| 1159F | 0% | 56,192 | $0.00 | |
| 91308 | 0% | 178 | $0.00 | |
| 4004F | 0% | 50 | $0.00 | |
| 3077F | 0% | 2,104 | $0.00 | |
| 91312 | 0% | 73 | $0.00 | |
| 91313 | 0% | 56 | $0.00 | |
| 4124F | 0% | 35 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPINCINCE, DEBORAH (ADMINISTRATOR)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.